keyword
https://read.qxmd.com/read/38543137/the-current-therapeutic-landscape-for-metastatic-prostate-cancer
#21
REVIEW
Anastasia Bernal, Alivia Jane Bechler, Kabhilan Mohan, Angie Rizzino, Grinu Mathew
In 2024, there will be an estimated 1,466,718 cases of prostate cancer (PC) diagnosed globally, of which 299,010 cases are estimated to be from the US. The typical clinical approach for PC involves routine screening, diagnosis, and standard lines of treatment. However, not all patients respond to therapy and are subsequently diagnosed with treatment emergent neuroendocrine prostate cancer (NEPC). There are currently no approved treatments for this form of aggressive PC. In this review, a compilation of the clinical trials regimen to treat late-stage NEPC using novel targets and/or a combination approach is presented...
March 8, 2024: Pharmaceuticals
https://read.qxmd.com/read/38522235/empagliflozin-mitigates-cardiac-hypertrophy-through-cardiac-rsk-nhe-1-inhibition
#22
JOURNAL ARTICLE
Sha Chen, Kenneth Overberg, Zakiya Ghouse, Markus W Hollmann, Nina C Weber, Ruben Coronel, Coert J Zuurbier
BACKGROUND: SGLT2i reduce cardiac hypertrophy, but underlying mechanisms remain unknown. Here we explore a role for serine/threonine kinases (STK) and sodium hydrogen exchanger 1(NHE1) activities in SGLT2i effects on cardiac hypertrophy. METHODS: Isolated hearts from db/db mice were perfused with 1 µM EMPA, and STK phosphorylation sites were examined using unbiased multiplex analysis to detect the most affected STKs by EMPA. Subsequently, hypertrophy was induced in H9c2 cells with 50 µM phenylephrine (PE), and the role of the most affected STK (p90 ribosomal S6 kinase (RSK)) and NHE1 activity in hypertrophy and the protection by EMPA was evaluated...
March 23, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38521968/the-effects-of-aurora-kinase-inhibition-on-thyroid-cancer-growth-and-sensitivity-to-mapk-directed-therapies
#23
JOURNAL ARTICLE
Hannah M Hicks, Veronica L Nassar, Jane Lund, Madison M Rose, Rebecca E Schweppe
Thyroid cancer is one of the deadliest endocrine cancers, and its incidence has been increasing. While mutations in BRAF are common in thyroid cancer, advanced PTC patients currently lack therapeutic options targeting the MAPK pathway, and despite the approved combination of BRAF and MEK1/2 inhibition for BRAF- mutant ATC, resistance often occurs. Here, we assess growth and signaling responses to combined BRAF and MEK1/2 inhibition in a panel of BRAF- mutant thyroid cancer cell lines. We first showed that combined BRAF and MEK1/2 inhibition synergistically inhibits cell growth in four out of six of the - BRAF -mutant thyroid cancer cell lines tested...
December 31, 2024: Cancer Biology & Therapy
https://read.qxmd.com/read/38521474/suppression-of-nsclc-progression-via-the-co-administration-of-danusertib-an-aurk-inhibitor-and-kribb11-an-hsf1-inhibitor
#24
JOURNAL ARTICLE
Xiang Zhang, Ying Lei, Xiang Chen, Jiahuang He, Zitian Liu, Wentao Zhu, Yi Xu, Xuru Jin
Aurora kinase (AURK) and heat shock factor 1 (HSF1) are commonly overexpressed in non-small cell lung cancer (NSCLC), correlating with poor prognosis. This study aims to assess the therapeutic potential of combining the Danusertib (Danu, AURK inhibitor) and KRIBB11 (HSF1 inhibitor) for NSCLC treatment. The effects of this combination were investigated in A549 cells and a tumor xenograft mouse model. The findings demonstrate that concurrent administration of Danu and KRIBB11 effectively impedes cell proliferation, induces apoptosis, and triggers G2/M cell cycle arrest...
March 21, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38516642/label-free-quantitative-proteomics-reveals-the-mechanisms-of-aurora-kinase-b-in-renal-cell-carcinoma
#25
JOURNAL ARTICLE
Yulong Li, Yang Yang
BACKGROUND: Renal cell carcinoma is the most common form of kidney cancer which is a global threat to human health, needing to explore effective therapeutic targets and treatment methods. Aurora kinase B acts as an important carcinogenic role in various kinds of tumors, while its mechanism in renal cell carcinoma is indistinct. Herein we explore the underlying mechanism of Aurora kinase B in renal cell carcinoma. METHODS AND RESULTS: Label-free quantitative proteomics analysis was employed to analyze the differentially expressed proteins in 786-O cells which were treated with si-Aurora kinase B or si-ctrl...
2024: SAGE Open Medicine
https://read.qxmd.com/read/38515112/aurkb-promotes-bladder-cancer-progression-by-deregulating-the-p53-dna-damage-response-pathway-via-mad2l2
#26
JOURNAL ARTICLE
Linzhi Li, Pengcheng Jiang, Weimin Hu, Fan Zou, Ming Li, Ting Rao, Yuan Ruan, Weimin Yu, Jinzhuo Ning, Fan Cheng
BACKGROUND: Bladder cancer (BC) is the most common urinary tract malignancy. Aurora kinase B (AURKB), a component of the chromosomal passenger protein complex, affects chromosomal segregation during cell division. Mitotic arrest-deficient 2-like protein 2 (MAD2L2) interacts with various proteins and contributes to genomic integrity. Both AURKB and MAD2L2 are overexpressed in various human cancers and have synergistic oncogenic effects; therefore, they are regarded as emerging therapeutic targets for cancer...
March 21, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38510242/antibody-dependent-cellular-cytotoxicity-inducing-anti-egfr-antibodies-as-effective-therapeutic-option-for-cutaneous-melanoma-resistant-to-braf-inhibitors
#27
JOURNAL ARTICLE
Elena Muraro, Barbara Montico, Benedict Lum, Francesca Colizzi, Giorgio Giurato, Annamaria Salvati, Roberto Guerrieri, Aurora Rizzo, Elisa Comaro, Vincenzo Canzonieri, Andrea Anichini, Michele Del Vecchio, Roberta Mortarini, Massimo Milione, Alessandro Weisz, Maria Antonietta Pizzichetta, Fiona Simpson, Riccardo Dolcetti, Elisabetta Fratta, Luca Sigalotti
INTRODUCTION: About 50% of cutaneous melanoma (CM) patients present activating BRAF mutations that can be effectively targeted by BRAF inhibitors (BRAFi). However, 20% of CM patients exhibit intrinsic drug resistance to BRAFi, while most of the others develop adaptive resistance over time. The mechanisms involved in BRAFi resistance are disparate and globally seem to rewire the cellular signaling profile by up-regulating different receptor tyrosine kinases (RTKs), such as the epidermal growth factor receptor (EGFR)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38508544/a-comprehensive-review-on-role-of-aurora-kinase-inhibitors-akis-in-cancer-therapeutics
#28
REVIEW
Deepali Gupta, Mukesh Kumar, Sana Saifi, Shivani Rawat, A S Ethayathulla, Punit Kaur
Aurora kinases (AURKs) are a family of serine /threonine protein kinases that have a crucial role in cell cycle process mainly in the event of chromosomal segregation, centrosome maturation and cytokinesis. The family consists of three members including Aurora kinase A (AURK-A), Aurora kinase B (AURK-B) and Aurora kinase C (AURK-C). All AURKs contain a conserved kinase domain for their activity but differ in their cellular localization and functions. AURK-A and AURK-B is expressed mainly in somatic cells while the expression of AURK-C is limited to germ cells...
March 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38499265/patient-derived-tumoroid-models-of-pulmonary-large-cell-neuroendocrine-carcinoma-a-promising-tool-for-personalized-medicine-and-developing-novel-therapeutic-strategies
#29
JOURNAL ARTICLE
Etsuko Yokota, Miki Iwai, Takuro Yukawa, Yoshio Naomoto, Minoru Haisa, Yasumasa Monobe, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Pulmonary large-cell neuroendocrine carcinoma (LCNEC), a disease with poor prognosis, is classified as pulmonary high-grade neuroendocrine carcinoma, along with small-cell lung cancer. However, given its infrequent occurrence, only a limited number of preclinical models have been established. Here, we established three LCNEC tumoroids for long-term culture. Whole-exome sequencing revealed that these tumoroids inherited genetic mutations from their parental tumors; two were classified as small-cell carcinoma (S-LCNEC) and one as non-small cell carcinoma (N-LCNEC)...
March 16, 2024: Cancer Letters
https://read.qxmd.com/read/38496702/determinants-of-aurora-kinase-b-inhibitor-sensitivity-in-small-cell-lung-cancer
#30
EDITORIAL
Lei Duan, Carl G Maki
No abstract text is available yet for this article.
February 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38488018/temporally-distinct-roles-of-aurora-a-in-polarization-of-the-c-elegans-zygote
#31
JOURNAL ARTICLE
Nadia I Manzi, Bailey N de Jesus, Yu Shi, Daniel J Dickinson
During asymmetric cell division, cell polarity is coordinated with the cell cycle to allow proper inheritance of cell fate determinants and generation of cellular diversity. In the Caenorhabditis elegans (C. elegans) zygote, polarity is governed by evolutionarily conserved Partitioning-defective (PAR) proteins that segregate to opposing cortical domains to specify asymmetric cell fates. Timely establishment of PAR domains requires a cell cycle kinase, Aurora A (AIR-1 in C. elegans). Aurora A depletion by RNAi causes a spectrum of phenotypes including reversed polarity, excess posterior domains, and no posterior domain...
March 15, 2024: Development
https://read.qxmd.com/read/38479814/the-golgi-checkpoint-golgi-unlinking-during-g2-is-necessary-for-spindle-formation-and-cytokinesis
#32
JOURNAL ARTICLE
Fabiola Mascanzoni, Inmaculada Ayala, Roberta Iannitti, Alberto Luini, Antonino Colanzi
Entry into mitosis requires not only correct DNA replication but also extensive cell reorganization, including the separation of the Golgi ribbon into isolated stacks. To understand the significance of pre-mitotic Golgi reorganization, we devised a strategy to first block Golgi segregation, with the consequent G2-arrest, and then force entry into mitosis. We found that the cells forced to enter mitosis with an intact Golgi ribbon showed remarkable cell division defects, including spindle multipolarity and binucleation...
May 2024: Life Science Alliance
https://read.qxmd.com/read/38471204/the-noncanonical-function-of-borealin-a-component-of-chromosome-passenger-complex-promotes-glycolysis-via-stabilization-of-survivin-in-squamous-cell-carcinoma-cells
#33
JOURNAL ARTICLE
Hiroaki Tawara, Takaaki Tsunematsu, Shojiro Kitajima, Ruka Nagao, Shigefumi Matsuzawa, Kunihiro Otsuka, Aya Ushio, Naozumi Ishimaru
The chromosome passenger complex (CPC) is a kinase complex formed by Aurora B, borealin, survivin and inner centromere protein (INCENP). The CPC is active during mitosis and contributes to proper chromosome segregation via the phosphorylation of various substrates. Overexpression of each CPC component has been reported in most cancers. However, its significance remains unclear, as only survivin is known to confer chemoresistance. This study showed that the overexpression of borealin, a CPC component, stabilized survivin protein depending on its interaction with survivin...
March 6, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38462449/the-role-of-aurora-b-kinase-in-normal-and-cancer-cells
#34
REVIEW
Ekaterina Titova, Galina Shagieva, Vera Dugina, Pavel Kopnin
Aurora kinases are essential players in mammalian cell division. These kinases are involved in the regulation of spindle dynamics, microtubule-kinetochore interactions, and chromosome condensation and orientation during mitosis. At least three members of the Aurora family - Aurora kinases A, B, and C - have been identified in mammals. Aurora B is essential for maintaining genomic stability and normal cell division. Mutations and dysregulation of this kinase are implicated in tumor initiation and progression...
December 2023: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38461274/correction-aurora-kinase-targeting-in-lung-cancer-reduces-kras-induced-transformation
#35
Edmilson Ozorio Dos Santos, Tatiana Correa Carneiro-Lobo, Mateus Nobrega Aoki, Elena Levantini, Daniela Sanchez Bassères
No abstract text is available yet for this article.
March 9, 2024: Molecular Cancer
https://read.qxmd.com/read/38460487/discovery-of-n-benzylbenzamide-based-allosteric-inhibitors-of-aurora-kinase-a
#36
JOURNAL ARTICLE
Hyomin Lee, Euijung Kim, Narae Hwang, Jesik Yoo, Yunju Nam, Injeoung Hwang, Jin-Gyeong Park, Sang-Eun Park, Kyung-Sook Chung, Hwan Won Chung, Chiman Song, Mi-Jung Ji, Hyun-Mee Park, In-Kyun Lee, Kyung-Tae Lee, Eun Joo Roh, Wooyoung Hur
Aurora kinases (AurkA/B/C) regulate the assembly of bipolar mitotic spindles and the fidelity of chromosome segregation during mitosis, and are attractive therapeutic targets for cancers. Numerous ATP-competitive AurkA inhibitors have been developed as potential anti-cancer agents. Recently, a few allosteric inhibitors have been reported that bind to the allosteric Y-pocket within AurkA kinase domain and disrupt the interaction between AurkA and its activator TPX2. Herein we report a novel allosteric AurkA inhibitor (6h) of N-benzylbenzamide backbone...
February 27, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38459127/structure-of-the-human-outer-kinetochore-kmn-network-complex
#37
JOURNAL ARTICLE
Stanislau Yatskevich, Jing Yang, Dom Bellini, Ziguo Zhang, David Barford
Faithful chromosome segregation requires robust, load-bearing attachments of chromosomes to the mitotic spindle, a function accomplished by large macromolecular complexes termed kinetochores. In most eukaryotes, the constitutive centromere-associated network (CCAN) complex of the inner kinetochore recruits to centromeres the ten-subunit outer kinetochore KMN network that comprises the KNL1C, MIS12C and NDC80C complexes. The KMN network directly attaches CCAN to microtubules through MIS12C and NDC80C. Here, we determined a high-resolution cryo-EM structure of the human KMN network...
March 8, 2024: Nature Structural & Molecular Biology
https://read.qxmd.com/read/38456722/effects-of-ferritin-heavy-chain-on-oxidative-stress-cell-proliferation-and-apoptosis-in-geese-follicular-granulosa-cells
#38
JOURNAL ARTICLE
D Jiang, X An, Q Xu, G Mo, W Ling, C Ji, Z Wang, X Wang, Q Sun, B Kang
1. The ferritin heavy chain (FHC) has a vital impact on follicular development in geese, due to its ability to regulate apoptosis of granulosa cells (GCs) and follicular atresia. However, its specific regulatory mechanisms remain unclear. The present study characterised how FHC regulates oxidative stress, cell proliferation and apoptosis in goose GCs by interfering with and overexpressing the FHC gene.2. After 72 h of interference with FHC expression, the activity of GCs decreased remarkably ( p  < 0...
March 8, 2024: British Poultry Science
https://read.qxmd.com/read/38454247/the-supression-of-migration-and-metastasis-via-inhibition-of-vascular-endothelial-growth-factor-in-pancreatic-adenocarcinoma-cells-applied-danusertib
#39
JOURNAL ARTICLE
Erkan Alabaş, Ahmet Ata Özçimen
BACKGROUND/AIMS: Pancreatic ductal adenocarcinoma is an extremely deadly type of cancer with a high metastatic potential. Genetic factors in cellular events play an important role in the emergence of this situation. One of these factors is Aurora kinase family members, which play a role in migration, invasion, and cell cycle. In this study, the expression of vascular endothelial growth factor gene, which plays a role in migration, metastasis, and angiogenesis, on cystic fibrosis human pancreatic ductal adenocarcinoma 1 cells of danusertib, a pan-Aurora kinase inhibitor, was examined...
February 2024: Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology
https://read.qxmd.com/read/38454090/neuropathological-stage-dependent-proteome-mapping-of-the-olfactory-tract-in-alzheimer-s-disease-from-early-olfactory-related-omics-signatures-to-computational-repurposing-of-drug-candidates
#40
JOURNAL ARTICLE
Paz Cartas-Cejudo, Adriana Cortés, Mercedes Lachén-Montes, Elena Anaya-Cubero, Elena Puerta, Maite Solas, Joaquín Fernández-Irigoyen, Enrique Santamaría
Alzheimer's disease (AD) is the most common form of dementia, characterized by an early olfactory dysfunction, progressive memory loss, and behavioral deterioration. Albeit substantial progress has been made in characterizing AD-associated molecular and cellular events, there is an unmet clinical need for new therapies. In this study, olfactory tract proteotyping performed in controls and AD subjects (n = 17/group) showed a Braak stage-dependent proteostatic impairment accompanied by the progressive modulation of amyloid precursor protein and tau functional interactomes...
March 7, 2024: Brain Pathology
keyword
keyword
14405
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.